Follow The Filings

CC Chemours

Chemours earnings company data as of 4:00 PM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 2 Nov EPS 0.26 — —
Rev $1.53B — —

Insider trades

Open-market buys and sales by CC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CC insider trades
  • $489K bought by 7 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Calderon Gerardo Familiar See Remarks
    Buy
    $30K 1,935 shares at $15.53 +3.4% to stake
    Traded Aug 12 Filed Aug 13
    ↗
  2. Denise Dignam CEO
    Buy
    $51K 3,378 shares at $14.95 +1% to stake
    Traded Aug 11 Filed Aug 13
    ↗
  3. Alister Cowan Director
    Buy
    $203K 13,000 shares at $15.62 +30% to stake
    Traded Aug 7 Filed Aug 11
    ↗
  4. Michael Robert Foley See Remarks
    Buy
    $30K 1,934 shares at $15.51
    Traded Aug 7 Filed Aug 11
    ↗
  5. Joseph T. Martinko See Remarks
    Buy
    $30K 1,940 shares at $15.47 +3.6% to stake
    Traded Aug 7 Filed Aug 11
    ↗
  6. Mary B Cranston Director
    Buy
    $95K 6,000 shares at $15.83 +5.6% to stake
    Traded Aug 7 Filed Aug 11
    ↗
  7. Shane Hostetter CFO
    Buy
    $50K 3,350 shares at $14.94 +3.4% to stake
    Traded Aug 6 Filed Aug 10
    ↗

Also filed in the last 12 months, not counted as buying or selling: 20 stock grants and 14 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 1.01,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 15 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf